SummitTX Capital »

Aligos Therapeutics shares owned by SummitTX Capital

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.3M 139k 9.32

More positions owned by SummitTX Capital

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Asml Holding N V N Y Registry Shs (ASML)
Eli Lilly & Co. (LLY)
MKS Instruments (MKSI)
Wal-Mart Stores (WMT)
Paypal Holdings (PYPL)
Applied Materials (AMAT)
Amazon (AMZN)
Anthem (ELV)
Costco Wholesale Corporation (COST)
UnitedHealth (UNH)
Meritage Homes Corporation (MTH)

View all positions for SummitTX Capital

Top funds holding Aligos Therapeutics

Deep Track Capital
Alyeska Investment Group
Sio Capital Management
Woodline Partners
Marshall Wace
Vanguard Group
SummitTX Capital
Renaissance Technologies
Baker Bros. Advisors
Two Sigma Investments
Hillhouse Capital Advisors
Verition Fund Management
LPL Financial
Citadel Advisors
Geode Capital Management

View all funds holding Aligos Therapeutics